A multivariate investigation into the relationship between pharmaceutical characteristics and patient preferences of bioequivalent ibuprofen tablets

References

• European Medicines AgencyGuideline on the Investigation of BioequivalenceLondonEMA2010 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdfAccessed March 7, 2018
   Google Scholar
• AlvarezCNúñezITorradoJJGordonJPotthastHGarcía-ArietaAInvestigation on the possibility of biowaivers for ibuprofenJ Pharm Sci201110062343234921491448
   PubMed Web of Science ®Google Scholar
• BramlagePGoldisABioequivalence study of three ibuprofen formulations after single dose administration in healthy volunteersBMC Pharmacol20088181818959779
   PubMedGoogle Scholar
• García-ArietaAAbad-SantosFRodríguez-MartínezMAAn eutomer/distomer ratio near unity does not justify non-enantiospecific assay methods in bioequivalence studiesChirality200517847047516104026
   PubMed Web of Science ®Google Scholar
• TorradoJJBlancoMFarréMRosetPGarcía-ArietaARationale and conditions for the requirement of chiral bioanalytical methods in bioequivalence studiesEur J Clin Pharmacol201066659960420195587
   PubMed Web of Science ®Google Scholar
• García-ArietaAFerrero-CafieroJMPuntesMImpact of chiral bioanalytical methods on the bioequivalence of ibuprofen products containing ibuprofen lysinate and ibuprofen baseChirality201628542943327094918
   PubMed Web of Science ®Google Scholar
• PotthastHDressmanJBJungingerHEBiowaiver monographs for immediate release solid oral dosage forms: ibuprofenJ Pharm Sci200594102121213116136567
   PubMed Web of Science ®Google Scholar
• RinakiEDokoumetzidisAValsamiGMacherasPIdentification of biowaivers among Class II drugs: theoretical justification and practical examplesPharm Res20042191567157215497681
   PubMed Web of Science ®Google Scholar
• RobertsMFordJLMacleodGSEffect of lubricant type and concentration on the punch tip adherence of model ibuprofen formulationsJ Pharm Pharmacol200456329930515025854
   PubMed Web of Science ®Google Scholar
• United States Pharmacopoeia38Rockville2015
   Google Scholar
• Food and Drug AdministrationGuidance for Industry Extended Release Oral Dosage Forms: Development, Evaluation and Application of In Vitro/In Vivo CorrelationsRockville, MDUS Department of Health and Human Services1997BP2 Available from: https://www.fda.gov/downloads/drugs/guidances/ucm070239.pdfAccessed March 7, 2018
   Google Scholar
• García-ArietaAGordonJPotthastHOn the biopharmaceutics classification system biowaiver of ibuprofenJ Pharm Sci201510482429243226036644
   PubMed Web of Science ®Google Scholar
• Agencia Española Medicamentos. Centro de Información Medicamentos Agencia Española (CIMA) Available from: https://www.aemps.gob.es/cimaAccessed September 7, 2018 Spanish
   Google Scholar
• Consejo General Colegios de FarmacéuticosCatálogo de Medicamentos [Catalog of Medicines]MadridConsejo General Colegios de Farmacéuticos2011 Spanish
   Google Scholar
• Consejo General Colegios de FarmacéuticosCatálogo de Medicamentos [Catalog of Medicines]MadridConsejo General Colegios de Farmacéuticos2015 Spanish
   Google Scholar
• European Pharmacopoeia7th edStrasbourg2011
   Google Scholar
• FarhaneZBonnierFByrneHJAn in vitro study of the interaction of the chemotherapeutic drug Actinomycin D with lung cancer cell lines using Raman micro-spectroscopyJ Biophotonics2018111e201700112
   Web of Science ®Google Scholar
• Spanish Health System (Ministerio de Sanidad y Consumo)Información Terapéutica del Sistema Nacional de Salud [Therapeutic information of the National Health System]201135124128 Available from: https://www.msssi.gob.es/biblioPublic/publicaciones/Accessed March 7, 2018 Spanish
   Google Scholar
• HalmeMLindenKKääriäKPatients’ Preferences for Generic and Branded Over-the-Counter Medicines: An Adaptive Conjoint Analysis ApproachPatient20092424325522273245
   PubMedGoogle Scholar
• ToverudELHartmannKHåkonsenHA Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges?Appl Health Econ Health Policy201513Suppl 1(Suppl. 1)3545
   Web of Science ®Google Scholar
• Costa-FontJRudisillCTanSLoyaltyBBrand loyalty, patients and limited generic medicines uptakeHealth Policy20141162–322423324573104
   PubMed Web of Science ®Google Scholar
• SeymourRAHawkesfordJEWeldonMBrewsterDAn evaluation of different ibuprofen preparations in the control of postoperative pain after third molar surgeryBr J Clin Pharmacol199131183872015175
   PubMed Web of Science ®Google Scholar
• DanielsSReaderSBerryPGoulderMOnset of analgesia with sodium ibuprofen, ibuprofen acid incorporating poloxamer and acetaminophen – a single-dose, double-blind, placebo-controlled study in patients with post-operative dental painEur J Clin Pharmacol200965434335319252905
   PubMed Web of Science ®Google Scholar
• MehlischDRSykesJIbuprofen blood plasma levels and onset of analgesiaInt J Clin Pract Suppl201317817838
   Google Scholar
• FaasseKMartinLRGreyAGambleGPetrieKJImpact of brand or generic labeling on medication effectiveness and side effectsHealth Psychol201635218719026462056
   PubMed Web of Science ®Google Scholar
• ColganSLFaasseKPereiraJAGreyAPetrieKJChanging perceptions and efficacy of generic medicines: An intervention studyHealth Psychol201635111246125327505191
   PubMed Web of Science ®Google Scholar
• LevyGHollisterLEFailure of USP disintegration test to asses physiologic availability of enteric coated tabletsNY State J Med19646430023005
   Google Scholar
• European Medicines AgencyICH Q6A specifications: Test procedures and acceptance criteria for new drug products: Chemical substancesInternational Conference on Harmonization1999 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002823.pdfAccessed May 28, 2018
   Google Scholar
• Al-GousousJLangguthPOral Solid Dosage Form Disintegration Testing – The Forgotten TestJ Pharm Sci201510492664267525546430
   PubMed Web of Science ®Google Scholar
• UebbingLKlumppLWebsterGKLöbenbergRJustification of disintegration testing beyond current FDA criteria using in vitro and in silico modelsDrug Des Devel Ther20171111631174
   PubMed Web of Science ®Google Scholar
• TsumeYLangguthPGarcia-ArietaAAmidonGLIn silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofenBiopharm Drug Dispos201233736637722815122
   PubMed Web of Science ®Google Scholar